bitBiome, Inc., a biotechnology company unlocking the potential of Earth’s microbes to drive the bioeconomy, today announced a strategic partnership with a leading contract manufacturing organization (CMO) to enable large-scale manufacturing and supply of enzymes, proteins, and other bio-based ingredients.This new partnership positions bitBiome as a fully integrated company, covering the entire biomanufacturing pipeline from discovery and development to production and delivery.

Known for its extensive microbial genome database, bitBiome has built a reputation for discovering and engineering novel enzymes, proteins, and ingredients. However, until now, it lacked in-house capacity for large-scale production. This collaboration fills that gap, enabling bitBiome to offer end-to-end biomanufacturing services. With this expanded capacity, the company can now deliver commercially viable, bio-based products for markets including food, cosmetics, pharmaceuticals, and industrial sectors—all while meeting regulatory requirements.

"With this partnership, bitBiome has not only the access to the largest genetic repository from which new products and ingredients can be discovered and developed, but we now have the full capacity to manufacture and produce those products at commercial scale, making bitBiome a clear partner for companies looking to streamline the path from discovery to full-scale manufacturing all while reducing time and cost," said CEO, Yuji Suzuki. "Our partner brings world-class manufacturing expertise and all logistic infrastructure to translate our cutting-edge technologies into tangible commercial products. This also allows a streamlined process for bitBiome products to rapidly enter commercialization."

About bitBiome, Inc.
bitBiome is pioneering the use of microbial diversity to fuel the future bioeconomy. Its proprietary single-cell microbial genome analysis technology, bit-MAP®, powers bit-GEM, a database of over 2.4 billion environmental microbial sequences—many of which are absent from public databases. This massive dataset, combined with bioinformatics, machine learning, and AI, supports bit-QED, the company’s discovery and engineering platform for developing enzymes, pathways, and strains tailored for commercial biomanufacturing. bitBiome’s mission is to transform both existing and emerging industries with novel, nature-based bio-products unavailable through conventional means.